Norovirus GII refers to genogroup II noroviruses, a highly diverse group of non-enveloped positive-sense RNA viruses within the genus Norovirus (family Caliciviridae) that are responsible for the majority of norovirus outbreaks worldwide. This group includes numerous genotypes, most notably the pandemic GII.4 strains.
Explanation
Genogroup II noroviruses share the characteristic features of the Norovirus genus. They are non‑enveloped, with an icosahedral capsid approximately 27–40 nm in diameter. Their genome consists of a single-stranded positive-sense RNA molecule about 7.5 kb long that encodes non‑structural proteins on ORF1 and the capsid proteins VP1 and VP2 on ORFs 2 and 3. Genogroup II is the most genetically diverse of the human noroviruses; more than twenty genotypes have been identified. GII viruses replicate in intestinal epithelial cells, causing villus atrophy and disruption of absorptive functions. They are transmitted by the faecal–oral route and are notable for their low infectious dose, high environmental stability and resistance to common disinfectants. Symptoms typically include sudden onset of vomiting, profuse watery diarrhoea and abdominal cramps that resolve within a few days. Immunity is strain‑specific and short‑lived, permitting frequent reinfections.
Outbreaks and Global Impact
Noroviruses are a leading cause of acute gastroenteritis, with an estimated 685 million cases and 200,000 deaths worldwide each year. Genogroup II viruses account for most reported outbreaks, largely due to the success of the GII.4 lineage, which has periodically given rise to pandemic variants. These viruses spread rapidly in closed communities such as hospitals, nursing homes, schools and cruise ships, and they are responsible for both sporadic cases and large food-borne epidemics. Outbreaks have been associated with contaminated shellfish, fresh produce and person-to-person transmission. The high genetic diversity of GII noroviruses, along with their ability to undergo recombination, complicates vaccine development. Preventive measures emphasise strict hygiene, safe food handling and rapid isolation of symptomatic individuals. Genogroup II noroviruses dominate the landscape of norovirus disease. Their small, resilient virions and rapidly evolving genomes enable them to spread efficiently and cause repeated waves of gastroenteritis across the globe. Continued surveillance and improved public health measures are essential to reduce their impact. Related Terms: Norovirus GI, Norovirus GIV, Sapovirus, Rotavirus B, Caliciviridae